Themis Medicare Ltd (THEMISMED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 469937,
    "name": "Themis Medicare",
    "stock_name": "Themis Medicare",
    "full_name": "Themis Medicare Ltd",
    "name_url": "stocks-analysis/themis-medicare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "81.20",
    "chg": 3.65,
    "chgp": "4.71%",
    "dir": 1,
    "prev_price": "77.55",
    "mcapval": "756.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530199,
    "symbol": "THEMISMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083B01024",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.04 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/themis-medicare-469937-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Themis Medicare Sees Revision in Market Evaluation Amid Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3737181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ThemisMedicare_mojoScore_3737181.png",
        "date": "2025-11-30 10:24:34",
        "description": "Themis Medicare, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and technical challenges. This shift highlights the company's current position amid a difficult operating environment and subdued investor sentiment."
      },
      {
        "title": "Themis Medicare Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-technical-momentum-shifts-amid-bearish-market-signals-3730179",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ThemisMedicare_technicaldot_3730179.png",
        "date": "2025-11-26 08:03:32",
        "description": "Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the challenges faced by the stock amid broader market dynamics."
      },
      {
        "title": "Themis Medicare Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-technical-momentum-shifts-amid-bearish-market-sentiment-3727484",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ThemisMedicare_technicaldot_3727484.png",
        "date": "2025-11-25 08:05:46",
        "description": "Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the challenges faced by the stock amid broader market dynamics."
      },
      {
        "title": "Why is Themis Medicare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-themis-medicare-fallingrising-3722085",
        "imagepath": "",
        "date": "2025-11-22 01:00:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downtrend and Market Underperformance</strong></p>\n<p>Themis Medicare’s stock has been on a downward trajectory for the past week, losing 7.15% compared to a modest 0.79% gain in the Sensex over the same period. The decline extends over the last month as well, with the stock falling 14.16% while the Sensex rose by nearly 1%. Year-to-date figures reveal a stark contrast, with Themis Medicare plunging 58.77% against the Sensex’s 9.08% gain. Over the last year, the stock has underperformed dramatically, dropping 62.27% while the benchmark index advanced by 10.47%. Even over a three-year horizon, the company’s 21.77% return trails the Sensex’s 39.39% growth, signalling sustained underperformance.</p>\n<p>On the day in question, the stock underperformed its sector by 2.91%, hitting an i..."
      },
      {
        "title": "Is Themis Medicare technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-themis-medicare-technically-bullish-or-bearish-3713889",
        "imagepath": "",
        "date": "2025-11-19 08:15:20",
        "description": "As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating mixed signals. The Bollinger Bands are bearish on both weekly and monthly time frames, and daily moving averages confirm a bearish outlook. The KST shows a bullish signal on the weekly but is bearish monthly, while Dow Theory indicates a mildly bearish stance on the weekly and mildly bullish on the monthly. Overall, the indicators suggest a prevailing bearish sentiment in the short to medium term...."
      },
      {
        "title": "Themis Medicare Technical Momentum Shifts Amid Bearish Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-technical-momentum-shifts-amid-bearish-signals-3714230",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ThemisMedicare_technicaldot_3714230.png",
        "date": "2025-11-19 08:04:29",
        "description": "Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from mildly bearish to bearish trends. Recent technical indicators reveal a complex interplay of signals, with the stock price currently at ₹114.00, down 1.60% from the previous close of ₹115.85, amid a 52-week range of ₹98.00 to ₹313.65."
      },
      {
        "title": "Themis Medicare Faces Financial Struggles Amidst Declining Sales and Profitability Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicares-financial-trend-shifts-from-negative-to-very-negative-amid-declining-performance-3709577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ThemisMedicare_fintrenddot_3709577.png",
        "date": "2025-11-18 08:00:22",
        "description": "Themis Medicare has reported a challenging financial quarter ending September 2025, marked by a significant decline in profit before tax and after tax, alongside decreased net sales. Despite achieving a high operating cash flow and a solid dividend payout ratio, key metrics indicate ongoing struggles and a lack of market confidence."
      },
      {
        "title": "Why is Themis Medicare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-themis-medicare-fallingrising-3708417",
        "imagepath": "",
        "date": "2025-11-17 22:45:03",
        "description": "As of 17-Nov, Themis Medicare Ltd is experiencing a decline in its stock price, currently at 116.15, which reflects a decrease of 0.7 or 0.6%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 5.45% during this period. Additionally, it is trading below all key moving averages, indicating a bearish trend. The stock has also underperformed its sector by 0.88% today, and its year-to-date performance shows a staggering drop of 55.86%. The company's financial health is concerning, with a significant decline in net sales of 20.08% and negative results reported for the last four consecutive quarters, leading to a negative EBITDA and a low return on capital employed.\n\nIn the broader market context, Themis Medicare's performance has been notably poor compared to the benchmark, as it has generated a return of -58.07% over the past year while the S..."
      },
      {
        "title": "Themis Medicare Faces Financial Challenges Amidst Strong Cash Flow and Dividend Payout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicares-financial-trend-improves-from-very-negative-to-negative-despite-ongoing-challenges-3701214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ThemisMedicare_fintrenddot_3701214.png",
        "date": "2025-11-14 11:01:20",
        "description": "Themis Medicare has reported a challenging financial quarter ending September 2025, with significant declines in profit metrics and net sales. Despite achieving a record operating cash flow and a solid dividend payout, the company's stock has struggled, reflecting a stark contrast to broader market performance."
      }
    ],
    "total": 245,
    "sid": "469937",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/themis-medicare-469937"
  },
  "announcements": [
    {
      "caption": "General-Updates: Report On Special Window For Re-Lodgment Of Transfer Requests Of Physical Shares.",
      "datetime": "14-Jan-2026",
      "details": "Please refer to the attachment.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Please refer to the attachment.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Dec-2025",
      "details": "Please refer to the attachment.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Themis Medicare Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Themis Medicare Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Oct 23",
          "dt": "2023-10-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Themis Medicare Sees Revision in Market Evaluation Amid Challenging Financial Trends

2025-11-30 10:24:34

Themis Medicare, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and technical challenges. This shift highlights the company's current position amid a difficult operating environment and subdued investor sentiment.

Themis Medicare Technical Momentum Shifts Amid Market Challenges

2025-11-26 08:03:32

Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the challenges faced by the stock amid broader market dynamics.

Themis Medicare Technical Momentum Shifts Amid Market Volatility

2025-11-25 08:05:46

Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the challenges faced by the stock amid broader market dynamics.

Why is Themis Medicare falling/rising?

2025-11-22 01:00:41

Persistent Downtrend and Market Underperformance Themis Medicare’s stock has been on a downward trajectory for the past week, losing 7.15% compared to a modest 0.79% gain in the Sensex over the same period. The decline extends over the last month as well, with the stock falling 14.16% while the Sensex rose by nearly 1%. Year-to-date figures reveal a stark contrast, with Themis Medicare plunging 58.77% against the Sensex’s 9.08% gain. Over the last year, the stock has underperformed dramatically, dropping 62.27% while the benchmark index advanced by 10.47%. Even over a three-year horizon, the company’s 21.77% return trails the Sensex’s 39.39% growth, signalling sustained underperformance. On the day in question, the stock underperformed its sector by 2.91%, hitting an i...

Is Themis Medicare technically bullish or bearish?

2025-11-19 08:15:20

As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating mixed signals. The Bollinger Bands are bearish on both weekly and monthly time frames, and daily moving averages confirm a bearish outlook. The KST shows a bullish signal on the weekly but is bearish monthly, while Dow Theory indicates a mildly bearish stance on the weekly and mildly bullish on the monthly. Overall, the indicators suggest a prevailing bearish sentiment in the short to medium term....

Themis Medicare Technical Momentum Shifts Amid Bearish Trends

2025-11-19 08:04:29

Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from mildly bearish to bearish trends. Recent technical indicators reveal a complex interplay of signals, with the stock price currently at ₹114.00, down 1.60% from the previous close of ₹115.85, amid a 52-week range of ₹98.00 to ₹313.65.

Themis Medicare Faces Financial Struggles Amidst Declining Sales and Profitability Metrics

2025-11-18 08:00:22

Themis Medicare has reported a challenging financial quarter ending September 2025, marked by a significant decline in profit before tax and after tax, alongside decreased net sales. Despite achieving a high operating cash flow and a solid dividend payout ratio, key metrics indicate ongoing struggles and a lack of market confidence.

Why is Themis Medicare falling/rising?

2025-11-17 22:45:03

As of 17-Nov, Themis Medicare Ltd is experiencing a decline in its stock price, currently at 116.15, which reflects a decrease of 0.7 or 0.6%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 5.45% during this period. Additionally, it is trading below all key moving averages, indicating a bearish trend. The stock has also underperformed its sector by 0.88% today, and its year-to-date performance shows a staggering drop of 55.86%. The company's financial health is concerning, with a significant decline in net sales of 20.08% and negative results reported for the last four consecutive quarters, leading to a negative EBITDA and a low return on capital employed. In the broader market context, Themis Medicare's performance has been notably poor compared to the benchmark, as it has generated a return of -58.07% over the past year while the S...

Themis Medicare Faces Financial Challenges Amidst Strong Cash Flow and Dividend Payout

2025-11-14 11:01:20

Themis Medicare has reported a challenging financial quarter ending September 2025, with significant declines in profit metrics and net sales. Despite achieving a record operating cash flow and a solid dividend payout, the company's stock has struggled, reflecting a stark contrast to broader market performance.

View All News